Taking everything into account, MEDP scores 7 out of 10 in our fundamental rating. MEDP was compared to 57 industry peers in the Life Sciences Tools & Services industry. MEDP has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MEDP is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes MEDP very considerable for growth and quality investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.7% | ||
| ROE | 147.46% | ||
| ROIC | 91.45% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.5% | ||
| PM (TTM) | 18.36% | ||
| GM | 31.11% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.57 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.08 | ||
| Fwd PE | 35.79 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.05 | ||
| EV/EBITDA | 30.99 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:MEDP (1/13/2026, 10:35:43 AM)
601.71
+2.5 (+0.42%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 42.08 | ||
| Fwd PE | 35.79 | ||
| P/S | 7.19 | ||
| P/FCF | 25.05 | ||
| P/OCF | 23.83 | ||
| P/B | 57.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 30.99 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.7% | ||
| ROE | 147.46% | ||
| ROCE | 108.09% | ||
| ROIC | 91.45% | ||
| ROICexc | 233.48% | ||
| ROICexgc | N/A | ||
| OM | 21.5% | ||
| PM (TTM) | 18.36% | ||
| GM | 31.11% | ||
| FCFM | 28.7% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 120.93% | ||
| Cap/Sales | 1.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 132.81% | ||
| Profit Quality | 156.3% | ||
| Current Ratio | 0.57 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z | 8.39 |
ChartMill assigns a fundamental rating of 7 / 10 to MEDP.
ChartMill assigns a valuation rating of 4 / 10 to MEDPACE HOLDINGS INC (MEDP). This can be considered as Fairly Valued.
MEDPACE HOLDINGS INC (MEDP) has a profitability rating of 9 / 10.
The Price/Earnings (PE) ratio for MEDPACE HOLDINGS INC (MEDP) is 42.08 and the Price/Book (PB) ratio is 57.72.
The financial health rating of MEDPACE HOLDINGS INC (MEDP) is 8 / 10.